<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b309235f" hasDoc="yes" version="1085"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="New" advantage="None"/><text>New isocysteine building blocks and chemoselective peptide ligation</text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>Boc-, Fmoc- and Cbz-protected isocysteine building blocks were prepared by a concise three-step procedure starting from thiomalic acid.</text></s> <s sid="3"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>The use of Boc/Trt-protected isocysteine provided convenient access to isocysteinyl peptides that allow the chemoselective ligation of unprotected peptide fragments in water.</text></s> <s sid="4"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="New" advantage="None"/><text>The pH-dependency of the isocysteine-mediated ligation was compared with that of cysteine-mediated native chemical ligation.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER>Introduction</HEADER><P><s sid="5"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>The replacement of naturally occurring amino acids by isosteric or artificial amino acids is commonly employed for probing the interaction of a protein with its ligand.</text></s> <s sid="6"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Thiol-containing building blocks are of interest due to their particular reactivity which mediates inhibitory interactions with protein metallo centers, conformational restriction through disulfide bond formation and site-selective tagging reactions among other effects.</text></s> <s sid="7"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>The β-mercapto amino acid cysteine is by far the most frequently used thiol-containing building block.</text></s> <s sid="8"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Its 1,2-aminothiol structure also makes it an invaluable tool for the efficient and convenient joining of two unprotected peptide fragments.<REF ID="R-0" REFID="cit1"/><REF ID="R-1" REFID="cit2"/><REF ID="R-2" REFID="cit3"/><REF ID="R-3" REFID="cit4"/><REF ID="R-4" REFID="cit5"/></text></s></P><P><s sid="9"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/><text>The introduction of α-mercapto acids provides the opportunity to alter thiol acidity and/or thiolate basicity which can allow the fine-tuning of metal–ligand interactions.</text></s> <s sid="10"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>For example, some inhibitors of metalloproteases such as angiotensin-converting enzymes contain α-mercapto acyl peptides.<REF ID="R-5" REFID="cit6"/><REF ID="R-6" REFID="cit7"/></text></s> <s sid="11"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>The β-amino-α-mercapto amino acid isocysteine is a useful cysteine analogue and has been shown to increase the inhibitory activity of peptidic stromelysin binders when incorporated as a replacement of cysteine.<REF ID="R-7" REFID="cit8"/></text></s> <s sid="12"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>Isocysteine also might serve as a replacement of β3-H cysteine in β-peptides which opens the possibility of altering thiol reactivity without changing the backbone length.<REF ID="R-8" REFID="cit9"/></text></s> <s sid="13"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>There is, however, only one report that describes the preparation of an isocysteine derivative that suits the needs of solid-phase peptide synthesis.<REF ID="R-9" REFID="cit8"/></text></s> <s sid="14"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>We here present convenient syntheses of Boc-, Fmoc- and Cbz-protected isocysteine building blocks.</text></s> <s sid="15"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>Furthermore we show the utility of isocysteine to support the ligation of unprotected peptide segments by a native chemical ligation-like reaction.</text></s> <s sid="16"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="New" advantage="None"/><text>To illustrate the effects of alterations of the thiol acidity the pH-dependency of the isocysteine ligation was compared with that of cysteine-mediated native chemical ligation.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Results and discussion</HEADER><P><s sid="17"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Hanglows’ synthesis of isocysteine 7 and also our route to N,S-protected building blocks 8–11 was based on commercially available dl-thiomalic acid 1 as described by Gustavson.<REF ID="R-10" REFID="cit8"/><REF ID="R-11" REFID="cit10"/><REF ID="R-12" REFID="cit11"/></text></s> <s sid="18"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>According to this, simultaneous protection of both the α-mercapto and the α-carboxylic group was achieved upon reaction with cyclopentanone in the presence of p-toluenesulfonic acid (Scheme 1).</text></s> <s sid="19"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>The β-carboxyl group in the formed oxathiolanone 2 remained unaffected and was subsequently converted to the acyl azide.</text></s> <s sid="20"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="New" advantage="None"/><text>In contrast to Hanglows’ Fmoc/Trt-Isocys synthesis, in which the isocyanate 3 formed after the Curtius rearrangement was hydrolysed to obtain isocysteine in unprotected form, it was preferred to fashion a more direct establishing of Fmoc-, Cbz- and Boc-protecting groups.</text></s> <s sid="21"><CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/><text>The isocyanate 3 was allowed to react with 9-fluorenylmethanol, benzyl alcohol or tert-butanol, which completed a three-step sequence and furnished the fully protected isocysteine derivatives 4, 5 and 6 in 77–87percent yield.</text></s> <s sid="22"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><text>We next sought a method that would liberate both the carboxyl group and the α-mercapto group without detriment to the acid- and base-sensitive protecting groups in 4–6.</text></s> <s sid="23"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>The opening of the cyclic ketal was initiated by ester hydrolysis with aqueous LiOH in THF, which proved straightforward with Cbz- and Boc-protected isocysteines 4 and 6.</text></s> <s sid="24"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>The presence of the base-sensitive Fmoc-group in 5 rendered this step challenging.</text></s> <s sid="25"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>It was found that careful addition of exactly one equivalent of lithium hydroxide in THF, however, enabled a clean and quantitative removal of the ketal group.</text></s> <s sid="26"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="New" advantage="None"/><text>The liberated α-mercapto groups were subsequently masked by omitting any attempts to isolate the N-protected isocysteine derivatives.</text></s> <s sid="27"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="New" advantage="None"/><text>Instead, it was preferred to directly add p-methoxybenzyl chloride or trityl bromide to the basic THF solution obtained after ester hydrolysis.</text></s> <s sid="28"><CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><text>This convenient one-pot procedure afforded the known Fmoc/Trt-protected isocysteine 7 and the novel Fmoc/PMB-, Cbz/PMB-, Boc/Trt- and Boc/PMB-protected building blocks 8–11 in 50–96percent yield.</text></s> <s sid="29"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>It is noted that the same strategy would allow for the synthesis of enantiomerically pure isocysteine if d- or l-thiomalic acid were used.<REF ID="R-13" REFID="cit12"/></text></s></P><P><s sid="30"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="New" advantage="None"/><text>Having established expedient access to various protected isocysteine derivatives we next set out to explore their utility in the solid-phase synthesis of isocysteine containing peptides.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Previous work had demonstrated the usefulness of the Fmoc/Trt-protected building block 7.<REF ID="R-14" REFID="cit8"/></text></s> <s sid="32"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><text>We envisaged investigating the use of isocysteine as a ligation handle (vide infra).</text></s> <s sid="33"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><text>Our particular interest, therefore, concerned the synthesis of peptides such as 16 bearing isocysteine as N-terminal amino acid.</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/><text>We reckoned that Cbz/PMB- and Boc/PMB-protected isocysteine building blocks 9 and 11 would enable the isocysteinyl-peptide 16 to be assembled by applying the Boc-strategy.</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="None"/><text>For the final cleavage trifluoromethanesulfonic acid was employed as a non-toxic alternative to HF.</text></s> <s sid="36"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>The crude peptide obtained after cleavage, however, failed to precipitate upon addition of ether which hampered its purification.</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="New" advantage="None"/><text>After repeated unsuccessful attempts with various scavengers, we chose to couple Boc/Trt-protected isocysteine 10 to resin-bound peptide 14 which was assembled by using Fmoc/tBu-protected amino acids (Scheme 2).</text></s> <s sid="38"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="New" advantage="Yes"/><text>It was expected that the application of the Fmoc-strategy and TFA as cleaving agent would be beneficial.</text></s> <s sid="39"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="New" advantage="Yes"/><text>TFA in contrast to TFMSA (trifluoromethanesulfonic acid) is volatile and allows vacuum concentration thereby facilitating ether precipitation.</text></s> <s sid="40"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>Indeed, in this case purification was straightforward providing peptide 16 after HPLC purification in 69percent overall yield.</text></s></P><P><s sid="41"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>Terminally modified peptides such as bromoacetamido-,<REF ID="R-15" REFID="cit13"/> maleinimido-,<REF ID="R-16" REFID="cit14"/> hydroxylamino-<REF ID="R-17" REFID="cit15"/> and azidopeptides<REF ID="R-18" REFID="cit16"/><REF ID="R-19" REFID="cit17"/> among others<REF ID="R-20" REFID="cit18"/> are invaluable tools that can allow chemoselective ligation of two unprotected peptide fragments to be performed in aqueous solution.</text></s> <s sid="42"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>The 1,2-aminothiol structure of N-terminal cysteine is one of the most suitable entities for achieving such segment couplings demonstrated best by the numerous protein syntheses that have been enabled by the native chemical ligation technology.<REF ID="R-21" REFID="cit2"/><REF ID="R-22" REFID="cit19"/></text></s> <s sid="43"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>This reaction (Scheme 3) is initiated by a reversible thiol-exchange reaction of cysteine conjugate 17 with thioester 18.<REF ID="R-23" REFID="cit20"/></text></s> <s sid="44"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>The formed thioester intermediate 19 is subject to a spontaneous S–N-acyl shift, which establishes the α-peptide bond in product 20.</text></s> <s sid="45"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>In isocysteine, the 1,2-aminothiol structure is retained.</text></s> <s sid="46"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>Accordingly, isocysteine is expected to support fragment ligations by a native chemical ligation-like reaction mechanism.<REF ID="R-24" REFID="cit21"/></text></s> <s sid="47"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>The S–N-acyl shift in thioester-intermediate 22 would lead to the formation of a β-peptide bond in 23.</text></s> <s sid="48"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>The isocysteine-mediated native chemical ligation would hence offer prospects for a convergent assembly of peptides with β-amino acid architecture.<REF ID="R-25" REFID="cit9"/><REF ID="R-26" REFID="cit22"/><REF ID="R-27" REFID="cit23"/></text></s></P><P><s sid="49"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="New" advantage="None"/><text>To assess the feasibility of isocysteine-mediated native chemical ligation we explored model peptides and ligation conditions as described by Kent and co-workers.<REF ID="R-28" REFID="cit3"/><REF ID="R-29" REFID="cit24"/></text></s> <s sid="50"><CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/><text>First, peptide mercaptopropionamide thioester 24, which was obtained through solid-phase synthesis on a mercaptopropionic acid loaded Rink-resin, was converted to the more reactive mercaptobenzylester 25.</text></s> <s sid="51"><CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="New" advantage="None"/><text>Peptide thioester 25 was allowed to react with the isocysteine-peptide 16.</text></s> <s sid="52"><CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="New" advantage="Yes"/><text>Reactions were carried out in argon saturated 0.1 M phosphate buffer and in the presence of 4percent benzylmercaptan which helped to prevent thioester hydrolysis and to maintain a reducing environment.</text></s> <s sid="53"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>At pH 7 and 1 mM concentration of reactants the isocysteine-mediated native chemical ligation proceeded smoothly.</text></s> <s sid="54"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>HPLC/ESI-MS analysis showed a new peak that appeared at 16 min with an m/z that corresponded to ligation product 26 (Fig. 1).</text></s> <s sid="55"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>The ligation product formed lacked susceptibility to attempted hydrolysis by NaOH-treatment which provided support for the formation of a non-hydrolysable peptide bond.</text></s> <s sid="56"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>It can be concluded that isocysteine supports a native chemical ligation-like reaction.</text></s> <s sid="57"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>It is interesting to note that the S→N acyl transfer likely to be involved in the isocysteine ligation proceeds via main chain expansion as opposed to S→N acyl transfer involved in cysteine and auxiliary mediated ligations<REF ID="R-30" REFID="cit25"/><REF ID="R-31" REFID="cit26"/><REF ID="R-32" REFID="cit27"/><REF ID="R-33" REFID="cit28"/><REF ID="R-34" REFID="cit29"/> that are characterised by main chain contraction.</text></s> <s sid="58"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>This feature might be of less importance in convergent peptide assembly, but we presume that it could affect ligation reactions that proceed under geometrical constraints such as peptide-<REF ID="R-35" REFID="cit30"/><REF ID="R-36" REFID="cit31"/> and DNA-template controlled reactions.<REF ID="R-37" REFID="cit32"/><REF ID="R-38" REFID="cit33"/></text></s></P><P><s sid="59"><CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/><text>It is worthwhile noting that both the isocysteine containing starting material 16 and the ligation product 26 exist as a mixture of diastereomers due to the use of racemic isocysteine.</text></s> <s sid="60"><CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/><text>Nevertheless, under the selected conditions the HPLC-traces showed single albeit broadened peaks and it was therefore not possible to explore whether one of the diastereomers conferred higher ligation rates than the other.</text></s></P><P><s sid="61"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>Fig. 2 shows the time-dependent formation of ligation product 26 at pH 7 and pH 6.</text></s> <s sid="62"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>It became evident that the ligation at pH 6 is slower than the ligation at pH 7.</text></s> <s sid="63"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>For example, product 26 was formed in 63percent yield after 240 min as opposed to 44percent yield obtained at pH 6.</text></s></P><P><s sid="64"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/><text>It has been shown that the cysteine-mediated native chemical ligation proceeds rapidly around pH 7 but is rendered less efficient at pH &lt; 5.5.<REF ID="R-39" REFID="cit34"/></text></s> <s sid="65"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="New" advantage="None"/><text>To explore whether the isocysteine-mediated native chemical ligation would exhibit a similar pH-dependence we compared the initial rate of formation of isocysteine-peptide 26 and cysteine-containing peptide 28 as a function of pH at 1 mM concentrations of reactants and at identical reaction conditions (Fig. 3).</text></s> <s sid="66"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>RP-HPLC-analysis revealed that the initial rate of cysteine native chemical ligation was reduced by a factor of 0.25 when lowering the pH from pH 7 to pH 6.</text></s> <s sid="67"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>This pH decrease reduced the initial rate of isocysteine native chemical ligation only by a factor of 0.56.</text></s> <s sid="68"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>Further pH decreases to pH 5 led to a diminution of initial rates such that the formation of ligation products almost ceased.</text></s> <s sid="69"><CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/><text>At pH 7, the ligation of cysteine-peptide 28 was 3-times faster than ligation of the isocysteine-peptide 26 while at pH &lt; 6, the isocysteine native chemical ligation was as efficient as the cysteine native chemical ligation.</text></s></P><P><s sid="70"><CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/><text>It became apparent that the isocysteine-mediated ligation is less pH-dependent than the cysteine-mediated native chemical ligation.</text></s> <s sid="71"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>We assume that the increased acidity of the thiol group is the decisive factor that leads to this attenuation of the pH-dependence.</text></s> <s sid="72"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>This assumption is based on the notion that native chemical ligation proceeds through the thiolate form of the cysteine-peptide and that the thiol-exchange reaction is rate-limiting.<REF ID="R-40" REFID="cit3"/></text></s> <s sid="73"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>In isocysteine, the α-thiol group should be more acidic than the β-thiol group of cysteine due to the inductive effect of the carboxyl group.</text></s> <s sid="74"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/><text>This influence becomes manifest in the pKa-value of thioglycolic amide (pKa = 8.2) which is considerably lower than that of β-mercaptopropionic amide (pKa = 9.4).<REF ID="R-41" REFID="cit35"/></text></s> <s sid="75"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>The calculated pKa-values of isocysteine amide (pKa = 8.2) and cysteine amide (pKa = 9.1) suggest a similar difference of thiol acidity.</text></s> <s sid="76"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>The more acidic the thiol group, the more thiolate is provided even under acidic conditions and hence the faster the ligation reaction.</text></s> <s sid="77"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>On the other hand, inductive and steric effects are expected to decrease the nucleophilicity of the α-thiolate in isocysteine when compared with the β-thiolate of cysteine which might explain why at pH &gt; 6 the cysteine native chemical ligation proved faster than the isocysteine native chemical ligation.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Conclusion</HEADER><P><s sid="78"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>In conclusion, we have provided convenient synthetic access to various isocysteine building blocks for solution and solid-phase peptide synthesis.</text></s> <s sid="79"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>The replacement of cysteine by isocysteine allows for an alteration of thiol reactivity as evidenced by the attenuated pH-dependence of isocysteine-mediated native chemical ligation of unprotected peptide fragments.</text></s> <s sid="80"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>Isocysteine being a β-amino acid, also might be incorporated in β-peptides, structurally well-defined peptide analogues that show interesting biological activities.</text></s> <s sid="81"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>It is, for example, conceivable that the replacement of β3-H-cysteine by isocysteine allows the thiol reactivity to be altered while maintaining the backbone length and the ability to confer chemoselective fragment condensations.</text></s> <s sid="82"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>In this regard, the ability of isocysteine to support native chemical ligation reactions might be of advantage for the convergent assembly of modified β-peptides.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Experimental</HEADER><DIV DEPTH="2"><HEADER>General materials and methods</HEADER><P><s sid="83"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Reagents and chemicals were obtained from Acros, Aldrich, Biosolve, Fluka, Novabiochem or Senn Chemicals and were used without further purification.</text></s> <s sid="84"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>All solvents were freshly distilled.</text></s> <s sid="85"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>Proton and carbon NMR spectra were recorded on a Varian Mercury 400 or a Bruker DRX-500 spectrometer at room temperature.</text></s> <s sid="86"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>The signals of the residual protonated solvent (CDCl3 or [D6]DMSO) were used as reference signals.</text></s> <s sid="87"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>Coupling constants J are reported in Hz.</text></s> <s sid="88"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/><text>Flash chromatography was performed using Merck silica gel 60.</text></s> <s sid="89"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/><text>TLC was performed with aluminium-backed silica gel 60 F254 plates (Merck).</text></s> <s sid="90"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/><text>Melting points were measured using a Büchi B-540 apparatus in open capillary tubes and are not corrected.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Reversed phase HPLC</HEADER><P><s sid="91"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Analytical reversed phase HPLC was performed with an Agilent 1100 series system and a DAD-detector recording at 280 nm.</text></s> <s sid="92"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>A Macherey &amp; Nagel Nucleosil (100-5) type CC 250/4 Nautilus RP-18 column was used at room temperature.</text></s> <s sid="93"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>Semi-preparative reversed phase HPLC was performed with a Gilson Nebula Series with automated fraction collection and Gilson 156 UV-detector.</text></s> <s sid="94"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>A Macherey &amp; Nagel SP 125/10 Nucleodur Gravity RP-18 column was used at 55 °C.</text></s> <s sid="95"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>Gradients of solvent A (98.9percent water/1percent acetonitrile/0.1percent TFA) and B (98.9percent acetonitrile/1percent water/0.1percent TFA) were adjusted according to the separation needs.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Mass spectrometry</HEADER><P><s sid="96"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>Matrix assisted laser desorption ionisation analysis was carried out with a Voyager-DE Pro BioSpectrometer™ from PerSeptive Biosystems using a 2,5-dihydroxybenzoic acid (DHB) matrix.</text></s> <s sid="97"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>ESI-MS was carried out using a Agilent 1100 series system with a Macherey &amp; Nagel Nucleosil (100-5) type CC 250/4 Nautilus RP-18 column and a Finnigan Thermoquest LCQ.</text></s> <s sid="98"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>FAB-MS was recorded on a JEOL JMS-SX102A machine, applied matrices were given for each compound.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Solid-phase peptide synthesis</HEADER><P><s sid="99"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Reactions were carried out at room temperature and performed manually using 5 ml polyethylene syringe reactors which were equipped with a fritted disc.</text></s> <s sid="100"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>All peptides were synthesised using HBTU/HOBt chemistry.</text></s> <s sid="101"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Typically 4 eq. of the corresponding amino acid were allowed to react for 2–3 min with 3.6 eq. of HBTU, 4 eq. of HOBt and 8 eq. of DIPEA in DMF/CH2Cl2 (1 : 1).</text></s> <s sid="102"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>The solution was added to the resin and agitated for 2 h at room temperature.</text></s> <s sid="103"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Cysteine was coupled using DIC/HOBt chemistry in order to avoid extensive racemisation.</text></s> <s sid="104"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Typically 4 eq. of the amino acid were reacted with 4 eq. of HOBt and 4 eq. of DIC in DMF for 20 min and then added to the resin.</text></s> <s sid="105"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Unreacted amino groups were capped by a 15 min treatment of pyridine/Ac2O (5 : 1) after every coupling step.</text></s> <s sid="106"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Fmoc cleavage was achieved using two times a solution of 20percent piperidine in DMF for 10 min.</text></s> <s sid="107"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>The Boc group was cleaved using two times pure TFA for 5 min.</text></s> <s sid="108"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>The resins were washed after every step with CH2Cl2 (5×), DMF (5×) and CH2Cl2 (5×) to avoid any side reactions.</text></s></P></DIV><DIV DEPTH="2"><HEADER>(2-Oxo-1-oxa-4-thia-spiro[4.4]non-3-yl)-acetic acid (2)</HEADER><P><s sid="109"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>To a solution of 2-mercaptosuccinic acid 1 (5.0 g, 33.3 mmol) in toluene (70 ml) were added cyclopentanone (3.54 ml, 40.2 mmol) and p-toluenesulfonic acid (76 mg, 0.40 mmol).</text></s> <s sid="110"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The reaction vessel was equipped with a Dean–Stark trap and was refluxed for 8 h.</text></s> <s sid="111"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The solution was concentrated under reduced pressure, and the residue was dissolved in sat.</text></s> <s sid="112"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>NaHCO3 (30 ml).</text></s> <s sid="113"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The aqueous solution was washed with CH2Cl2 (2 × 20 ml), adjusted to pH 2 with concentrated HCl and extracted with CH2Cl2 (3 × 30 ml).</text></s> <s sid="114"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The organic phase was dried (MgSO4) and evaporated under reduced pressure.</text></s> <s sid="115"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>The residue was purified by silica gel flash chromatography to furnish 4.90 g (68percent) of 2 as a white solid.</text></s> <datasection id="o939" type="dataSection"><s sid="116"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>Mp = 93 °C.</text></s> <s sid="117"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>Rf = 0.21 (EtOAc : cyclohexane) = 2 : 5 + 1percent AcOH).</text></s> <s sid="118"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>1H-NMR (CDCl3): δ 1.75 (m, 4H); 1.94 (m, 2H); 2.24 (m, 2H); 2.84 (dd, 1H, J = 9.16, J = 17.69); 3.21 (dd, 1H, J = 4.02, J = 17.57); 4.38 (dd, 1H, J = 4.14, J = 9.16); 11.43 (s, 1H).</text></s> <s sid="119"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>13C-NMR (CDCl3): 24.89 (CH2); 25.17 (CH2); 39.15 (CH2); 42.63 (CH2); 43.94 (CH2); 44.93 (CH); 97.20 (Cq); 174.83 (Cq); 177.59 (Cq).</text></s> <s sid="120"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="121"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>216.0456; found 216.0468.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>(2-Oxo-1-oxa-4-thia-spiro[4.4]non-3-ylmethyl)-carbamic acid benzyl ester (4)</HEADER><P><s sid="122"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>A solution of 2 (1.02 g, 4.73 mmol) and triethylamine (728 µl, 5.20 mmol) in toluene (20 ml) was stirred 30 min at room temperature.</text></s> <s sid="123"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The reaction mixture was cooled to 0 °C and diphenylphosphoryl azide (1.12 ml, 5.10 mmol) was added dropwise.</text></s> <s sid="124"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>After stirring for 2 h at room temperature, the solution was heated to 85 °C until the evolution of N2 ceased.</text></s> <s sid="125"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The reaction mixture was cooled to room temperature and EtOAc (30 ml) was added.</text></s> <s sid="126"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The organic phase was washed with sat.</text></s> <s sid="127"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>NaHCO3 (20 ml), dist.</text></s> <s sid="128"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>H2O (20 ml), dried (MgSO4) and concentrated under reduced pressure.</text></s> <s sid="129"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The residue was dissolved in toluene (20 ml) and benzyl alcohol (460 µl, 4.45 mmol) was added.</text></s> <s sid="130"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The solution was kept at 80 °C for 14 h and then allowed to cool to room temperature.</text></s> <s sid="131"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>The solvent was evaporated under reduced pressure and the residue was purified by silica gel chromatography to afford 1.32 g (87percent) of 4 as an yellow oil.</text></s> <datasection id="o940" type="dataSection"><s sid="132"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>Rf = 0.24 (EtOAc : cyclohexane = 4 : 1).</text></s> <s sid="133"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>1H-NMR (CDCl3): δ 1.75 (m, 4H); 1.94 (m, 2H); 2.24 (m, 2H); 3.65 (m, 2H); 4.19 (dd, 1H, J = 5.65); 5.07 (s, 2H); 7.31 (m, 5H).</text></s> <s sid="134"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/><text>13C-NMR (CDCl3): 23.58 (CH2); 23.84 (CH2); 41.34 (CH2); 42.53 (2 × CH2); 48.29 (CH2); 67.12 (CH2); 95.85 (Cq); 128.24–128.73 (4 × CH); 136.33 (Cq); 156.42 (Cq); 173.43 (Cq).</text></s> <s sid="135"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="136"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/><text>321.1035; found 321.1020.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>(2-Oxo-1-oxa-4-thia-spiro[4.4]non-3-ylmethyl)-carbamic acid 9H-fluoren-9-ylmethyl ester (5)</HEADER><P><s sid="137"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>A solution of 2 (200 mg, 0.92 mmol) and triethylamine (142 µl, 1.01 mmol) in toluene (10 ml) was stirred 30 min at room temperature.</text></s> <s sid="138"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The reaction was cooled to 0 °C and diphenylphosphoryl azide (198 µl, 0.92 mmol) was added dropwise.</text></s> <s sid="139"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>After stirring over 2 h at room temperature, the solution was heated up to 85 °C until the evolution of N2 ceased.</text></s> <s sid="140"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The reaction was cooled to room temperature and EtOAc (20 ml) was added.</text></s> <s sid="141"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The organic phase was washed with sat.</text></s> <s sid="142"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>NaHCO3 (15 ml), dist.</text></s> <s sid="143"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>H2O (15 ml), dried (MgSO4) and concentrated under reduced pressure.</text></s> <s sid="144"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The dried residue was dissolved in toluene (10 ml) and 9-fluorenylmethanol (157 mg, 0.8 mmol) was added.</text></s> <s sid="145"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The solution was kept at 80 °C for 24 h and then allowed to cool to room temperature.</text></s> <s sid="146"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The solvent was evaporated under reduced pressure and the residue was purified by silica gel chromatography to afford 320 mg (85percent) of 5 as an yellow oil.</text></s> <datasection id="o941" type="dataSection"><s sid="147"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/><text>Rf = 0.22 (EtOAc : cyclohexane = 4 : 1).</text></s> <s sid="148"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/><text>1H-NMR (CDCl3): δ 1.75 (m, 4H); 1.94 (m, 2H); 2.24 (m, 2H); 3.66 (m, 2H); 4.20 (m, 1H); 4.37 (m, 2H); 7.28 (t, 2H, J = 7.40); 7.37 (t, 2H, J = 7.53); 7.56 (d, 2H, J = 7.53); 7.73 (d, 2H, J = 7.53).</text></s> <s sid="149"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/><text>13C-NMR (CDCl3): 23.67 (CH2); 23.95 (CH2); 41.42 (CH2); 42.53 (CH2); 42.66 (CH); 47.32 (CH); 48.36 (CH2); 67.28 (CH2); 95.70 (Cq); 120.22–127.93 (8 × CH); 130.01 (2 × Cq); 141.50 (Cq); 143.95 (Cq); 156.51 (Cq); 173.62 (Cq).</text></s> <s sid="150"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="151"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs17" novelty="None" advantage="None"/><text>409.1348; found 409.1335.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>(2-Oxo-1-oxa-4-thia-spiro[4.4]non-3-ylmethyl)-carbamic acid tert-butyl ester (6)</HEADER><P><s sid="152"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>A solution of 2 (200 mg, 0.70 mmol) and triethylamine (108 µl, 0.77 mmol) in toluene (10 ml) was stirred 30 min at room temperature.</text></s> <s sid="153"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The reaction was cooled to 0 °C and diphenylphosphoryl azide (160 µl, 0.77 mmol) was added dropwise.</text></s> <s sid="154"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>After stirring over 2 h at room temperature, the solution was heated to 85 °C until the evolution of N2 ceased.</text></s> <s sid="155"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The reaction was cooled to room temperature and EtOAc (20 ml) was added.</text></s> <s sid="156"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The organic phase was washed with sat.</text></s> <s sid="157"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>NaHCO3 (15 ml), dist.</text></s> <s sid="158"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>H2O (15 ml), dried (MgSO4) and concentrated under reduced pressure.</text></s> <s sid="159"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The residue was dissolved in toluene (10 ml) and tert-butanol (881 µl, 7.7 mmol) was added.</text></s> <s sid="160"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The solution was kept at 75 °C for 40 h and then allowed to cool to room temperature.</text></s> <s sid="161"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The solvent was evaporated under reduced pressure and the residue was purified by silica gel chromatography to afford 183 mg (73percent) of 6 as an yellow oil.</text></s> <datasection id="o942" type="dataSection"><s sid="162"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs18" novelty="None" advantage="None"/><text>Rf = 0.26 (EtOAc : cyclohexane = 4 : 1).</text></s> <s sid="163"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs19" novelty="None" advantage="None"/><text>1H-NMR (CDCl3): δ 1.42 (s 9H); 1.75 (m 2H); 1.94 (m, 2H); 2.24 (m, 2H); 3.59 (m, 2H); 4.18 (m, 1H).</text></s> <s sid="164"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs20" novelty="None" advantage="None"/><text>13C-NMR (CDCl3): 23.57 (CH2); 23.83 (CH2); 28.42 (CH3); 41.44 (CH2); 42.19 (CH2); 42.53 (2 × CH2); 48.35 (CH); 80.02 (Cq); 95.79 (Cq); 173.54 (Cq).</text></s> <s sid="165"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs21" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="166"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs21" novelty="None" advantage="None"/><text>287.1191; found 287.1186.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-tritylsulfanyl-propionic acid (7)</HEADER><P><s sid="167"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>To a solution of 5 (80 mg, 0.20 mmol) in THF (5 ml), cooled to 0 °C was added dropwise 0.2 M LiOH (1 ml).</text></s> <s sid="168"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>After 30 min the starting material was completely consumed and trityl bromide (110 mg, 0.40 mmol) was added.</text></s> <s sid="169"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The solution was stirred 3 h at room temperature and adjusted to pH ∼ 3 with AcOH.</text></s> <s sid="170"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The aqueous solution was extracted with EtOAc (3 × 10 ml).</text></s> <s sid="171"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The organic extract was dried (MgSO4), filtered and concentrated under reduced pressure.</text></s> <s sid="172"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The residue was purified by silica gel flash chromatography to furnish 57 mg (50percent) of 7 as a white solid.</text></s> <datasection id="o943" type="dataSection"><s sid="173"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs22" novelty="None" advantage="None"/><text>Mp = 128–130 °C.</text></s> <s sid="174"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs23" novelty="None" advantage="None"/><text>Rf = 0.36 (DCM : MeOH = 95 : 5 + 1percent AcOH).</text></s> <s sid="175"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs24" novelty="None" advantage="None"/><text>1H-NMR ([D6]-DMSO): δ 2.99 (m, 1H); 3.05 (m, 2H); 4.11–4.18 (m, 3H); 7.30–7.37 (m, 19H); 7.64 (t, 2H, J = 8.48); 7.87 (d, 2H, J = 7.48).</text></s> <s sid="176"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs25" novelty="None" advantage="None"/><text>13C-NMR ([D6]-DMSO): 36.54 (CH); 46.55 (CH); 67.40 (Cq); 79.80 (CH2); 126.89–129.24 (6 × CH); 140.68 (Cq); 143.79 (Cq); 144.17 (Cq); 155.60 (Cq); 176.94 (Cq).</text></s> <s sid="177"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs26" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="178"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs26" novelty="None" advantage="None"/><text>585.1974; found 585.1978.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-(4-methoxy-benzylsulfanyl)-propionic acid (8)</HEADER><P><s sid="179"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>To a solution of 5 (80 mg, 0.20 mmol) in THF (5 ml), cooled to 0 °C was added dropwise 0.2 M LiOH (1 ml).</text></s> <s sid="180"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>After 30 min the starting material was completely consumed and p-methoxybenzyl chloride (28 µl, 0.20 mmol) was added.</text></s> <s sid="181"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>The solution was stirred 2 h at 0 °C and adjusted to pH ∼ 3 with AcOH.</text></s> <s sid="182"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>The aqueous solution was extracted with EtOAc (3 × 10 ml).</text></s> <s sid="183"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>The organic extract was dried (MgSO4), filtered and concentrated under reduced pressure.</text></s> <s sid="184"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>The residue was purified by silica gel flash chromatography to furnish 73 mg (80percent) of 8 as a yellow oil.</text></s> <datasection id="o944" type="dataSection"><s sid="185"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs27" novelty="None" advantage="None"/><text>Rf = 0.35 (DCM : MeOH = 95 : 5 + 1percent AcOH).</text></s> <s sid="186"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs28" novelty="None" advantage="None"/><text>1H-NMR ([D6]-DMSO): δ 3.24 (m, 1H); 3.34 (m, 2H); 3.69 (m, 3H); 3.77 (m, 2H); 4.24 (m, 3H); 6.82 (d, 2H, J = 8.53); 7.23 (d, 2H, J = 8.53); 7.31 (t, 2H, J = 7.15); 7.40 (t, 2H, J = 7.40); 7.69 (t, 2H, J = 6.40); 7.88 (d, 2H, J = 7.53).</text></s> <s sid="187"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs29" novelty="None" advantage="None"/><text>13C-NMR ([D6]-DMSO): 34.31 (CH2); 41.98 (CH); 46.25 (CH2); 46.98 (CH); 55.30 (CH3); 65.92 (CH2); 114.12 (2 × CH); 120.46 (2 × CH); 125.58–129.73 (8 × CH); 130.46 (Cq); 141.05 (2 × Cq); 144.17 (2 × Cq); 156.48 (Cq); 158.59 (Cq); 172.73 (Cq).</text></s> <s sid="188"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs30" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="189"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs30" novelty="None" advantage="None"/><text>463.1453; found 463.1432.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>3-Benzyloxycarbonylamino-2-(4-methoxy-benzylsulfanyl)-propionic acid (9)</HEADER><P><s sid="190"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>To a solution of 4 (1.29 g, 4.01 mmol) in 20 ml THF was added at 0 °C dropwise 1 M LiOH (15 ml) and the reaction was stirred for 1 h at room temperature.</text></s> <s sid="191"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The mixture was treated with p-methoxybenzyl chloride (544 µl, 4.01 mmol) and stirred at room temperature for further 3 h.</text></s> <s sid="192"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The reaction was adjusted to pH ∼ 3 with AcOH and H2O (10 ml) was added.</text></s> <s sid="193"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The aqueous solution was extracted with EtOAc (3 × 20 ml).</text></s> <s sid="194"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The organic phase was dried (MgSO4) and evaporated under reduced pressure.</text></s> <s sid="195"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/><text>The residue was purified by silica gel flash chromatography to obtain 1.45 g (96percent) of 9 as a yellow oil.</text></s> <datasection id="o945" type="dataSection"><s sid="196"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs31" novelty="None" advantage="None"/><text>Rf = 0.34 (DCM : MeOH = 95 : 5 + 1percent AcOH).</text></s> <s sid="197"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs32" novelty="None" advantage="None"/><text>1H-NMR ([D6]-DMSO): δ 3.38 (m, 2H); 3.47 (m, 2H); 3.75 (s, 3H); 3.83 (m, 2H); 5.05 (s, 2H); 6.81 (d, 2H, J = 8.53); 7.23 (d, 2H, J = 8.53); 7.32 (m, 5H).</text></s> <s sid="198"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs33" novelty="None" advantage="None"/><text>13C-NMR ([D6]-DMSO): 35.40 (CH2); 41.04 (CH2); 44.99 (CH); 55.15 (CH3); 66.94 (CH2); 113.95 (2 × CH); 128.04–128.45 (4 × CH); 130.18 (2 × CH); 136.07 (Cq); 156.24 (Cq); 158.82 (Cq); 176.28 (Cq).</text></s> <s sid="199"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs34" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="200"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs34" novelty="None" advantage="None"/><text>375.1140; found 375.1160.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>3-tert-Butoxycarbonylamino-2-tritylsulfanyl-propionic acid (10)</HEADER><P><s sid="201"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>To a solution of 6 (344 mg, 1.17 mmol) in 10 ml THF was added dropwise 1 M LiOH (5 ml) at 0 °C.</text></s> <s sid="202"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The mixture was heated to room temperature, stirred for 1 h before trityl bromide (388 mg, 1.2 mmol) was added.</text></s> <s sid="203"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The solution was stirred for further 4 h and adjusted to pH ∼ 3 by AcOH.</text></s> <s sid="204"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>H2O (10 ml) was added and the aqueous solution was extracted with EtOAc (3 × 10 ml).</text></s> <s sid="205"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/><text>The organic phase was dried (MgSO4), concentrated under reduced pressure and the residue was purified by silica gel flash chromatography to furnish 419 mg (78percent) of 10 as a white solid.</text></s> <datasection id="o946" type="dataSection"><s sid="206"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs35" novelty="None" advantage="None"/><text>Mp = 58–60 °C.</text></s> <s sid="207"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs36" novelty="None" advantage="None"/><text>Rf = 0.32 (DCM : MeOH = 95 : 5 + 1percent AcOH).</text></s> <s sid="208"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs37" novelty="None" advantage="None"/><text>1H-NMR ([D6]-DMSO): δ 1.46 (s, 9H); 2.99 (m, 2H); 3.07 (m, 1H); 7.25–7.36 (m, 15H).</text></s> <s sid="209"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs38" novelty="None" advantage="None"/><text>13C-NMR ([D6]-DMSO): 28.17 (3 × CH3); 36.43 (CH2); 47.07 (CH); 67.35 (Cq); 77.69 (Cq); 126.93 (3 × CH); 128.08 (3 × CH); 129.21 (3 × CH); 144.15 (Cq); 155.01 (Cq); 172.28 (Cq).</text></s> <s sid="210"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs39" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="211"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs39" novelty="None" advantage="None"/><text>463.1817; found 463.1835.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>3-tert-Butoxycarbonylamino-2-(4-methoxy-benzylsulfanyl)-propionic acid (11)</HEADER><P><s sid="212"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>To a solution of 6 (90 mg, 0.31 mmol) in 5 ml THF was added dropwise 1 M LiOH (3 ml) at 0 °C.</text></s> <s sid="213"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>The mixture was heated to room temperature, stirred for 1 h before p-methoxybenzyl chloride (43 µl, 0.31 mmol) was added.</text></s> <s sid="214"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>The solution was stirred for further 3 h and adjusted to pH ∼ 3 by AcOH.</text></s> <s sid="215"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>H2O (10 ml) was added and the aqueous solution was extracted with EtOAc (3 × 10 ml).</text></s> <s sid="216"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/><text>The organic phase was dried (MgSO4), concentrated under reduced pressure and the residue was purified by silica gel flash chromatography to furnish 81 mg (77percent) of 11 as a yellow oil.</text></s> <datasection id="o947" type="dataSection"><s sid="217"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs40" novelty="None" advantage="None"/><text>Rf = 0.34 (DCM : MeOH = 95 : 5 + 1percent AcOH).</text></s> <s sid="218"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs41" novelty="None" advantage="None"/><text>1H-NMR ([D6]-DMSO): δ 1.36 (s, 9H); 3.18 (m, 2H); 3.28 (m, 2H); 3.72 (s, 3H); 3.75 (m, 2H); 6.86 (d, 2H); 7.23 (d, 2H).</text></s> <s sid="219"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs42" novelty="None" advantage="None"/><text>13C-NMR ([D6]-DMSO): 28.24 (3 × CH3); 33.92 (CH2); 46.13 (CH2); 55.05 (CH3); 62.61 (CH); 77.69 (Cq); 77.95 (Cq); 113.46 (CH); 113.83 (CH); 127.97 (Cq); 129.46 (CH); 130.18 (CH); 155.59 (Cq); 158.34 (Cq); 172.44 (Cq).</text></s> <s sid="220"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs43" novelty="None" advantage="None"/><text>HRMS [FAB, m-NBA, pos.]: calcd.</text></s> <s sid="221"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs43" novelty="None" advantage="None"/><text>341.1297; found 341.1282.</text></s></datasection></P></DIV><DIV DEPTH="2"><HEADER>Isocys-Arg-Ala-Glu-Tyr-Ser (16)</HEADER><P><s sid="222"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>52 mg of Wang resin (0.98 mmol g−1, 0.051 mmol) was used and the peptide assembly proceeded as described above (Fmoc-Ser(t-Bu)-OH, Fmoc-Tyr(t-Bu)-OH, Fmoc-Glu(t-Bu)-OH, Fmoc-Ala-OH, Fmoc-Arg(Pmc)-OH, Boc-Isocys(Trt)-OH).</text></s> <s sid="223"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>The peptide was released and deprotected by treating the resin with a solution of CF3COOH : PhSMe : Et3SiH : H2O (92 : 3 : 3 : 2, 2 ml) for 2 h.</text></s> <s sid="224"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>After filtration the resin was washed two times with pure TFA (1 ml).</text></s> <s sid="225"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>The combined filtrates were concentrated under reduced pressure and cold ether was added (5 ml).</text></s> <s sid="226"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>The precipitate was collected by centrifugation and washed two times with ether.</text></s> <s sid="227"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/><text>Purification by semi-preparative reversed phase HPLC and lyophilization furnished 33 mg (69percent) of 16 as a white powder.</text></s> <s sid="228"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs44" novelty="None" advantage="None"/><text>MS (MALDI-TOF, DHB, pos.): m/z: calcd. for C29H46N9O11S [M + H]: 728.8, found: 729.1.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Leu-Tyr-Lys-Ala-Gly-COS(CH2)2CONH2 (24)</HEADER><P><s sid="229"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>To 104 mg of MBHA resin (0.8 mmol g−1, 0.083 mmol) was added a solution of 3-tritylsulfanylpropionic acid (1.47 mg, 0.42 mmol), HBTU (159.3 mg, 0.42 mmol) and DIPEA (145 µl, 0.83 mmol) in DMF/DCM (1 : 1, 2 ml).</text></s> <s sid="230"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>After 14 h the trityl group was removed by means of a one hour treatment with CF3COOH : Et3SiH (95 : 5, 1 ml).</text></s> <s sid="231"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>The peptide assembly proceeded as described above (Boc-Gly-OH, Boc-Ala-OH, Boc-Lys(2-Cl-Z)-OH, Boc-Tyr(Bz)-OH, Boc-Leu-OH).</text></s> <s sid="232"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>The peptide was released and deprotected by treating the resin with a solution of CF3COOH : CF3SO3H : PhSMe : EDT (77 : 10 : 10 : 3, 2 ml) for 2 h.</text></s> <s sid="233"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>After filtration the resin was washed two times with pure TFA (1 ml).</text></s> <s sid="234"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>The combined filtrates were concentrated under reduced pressure and cold ether was added (5 ml).</text></s> <s sid="235"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>The precipitate was collected by centrifugation and washed two times with ether.</text></s> <s sid="236"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/><text>Purification by semi-preparative reversed phase HPLC and lyophilization furnished 35 mg (49percent) of 24 as a white powder.</text></s> <s sid="237"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs45" novelty="None" advantage="None"/><text>MS (MALDI-TOF, DHB, pos.): calcd. for C29H48N7O7S [M + H]: 638.8 found: 639.6.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Cys-Arg-Ala-Glu-Tyr-Ser (27)</HEADER><P><s sid="238"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>52 mg of Wang resin (0.98 mmol g−1, 0.051 mmol) were used and the peptide assembly proceeded as described above (Fmoc-Ser(t-Bu)-OH, Fmoc-Tyr(t-Bu)-OH, Fmoc-Glu(t-Bu)-OH, Fmoc-Ala-OH, Fmoc-Arg(Pmc)-OH, Fmoc-Cys(Trt)-OH).</text></s> <s sid="239"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>The peptide was released and deprotected by treating the resin with a solution of CF3COOH : PhSMe : Et3SiH : H2O (92 : 3 : 3 : 2, 2 ml) for 2 h.</text></s> <s sid="240"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>After filtration the resin was washed two times with pure TFA (1 ml).</text></s> <s sid="241"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>The combined filtrates were concentrated under reduced pressure and cold ether was added (5 ml).</text></s> <s sid="242"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>The precipitate was collected by centrifugation and washed two times with ether.</text></s> <s sid="243"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/><text>Purification by semi-preparative reversed phase HPLC and lyophilization furnished 38 mg (78percent) of 27 as a white powder.</text></s> <s sid="244"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs46" novelty="None" advantage="None"/><text>MS (MALDI-TOF, DHB, pos.): m/z: calcd. for C29H46N9O11S [M + H]: 728.8, found: 729.2.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Chemical ligations</HEADER><P><s sid="245"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>Leu-Tyr-Lys-Ala-Gly-COS(CH2)2CONH2 (24) (100 µl of 10 mM solution in H2O) was added to an argon saturated 0.1 M sodium phosphate buffer (800 µl) adjusted to the desired pH-value by addition of 2 M NaOH.</text></s> <s sid="246"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>Benzylmercaptan (40 µl) was added and the mixture was stirred until the starting material was completely consumed.</text></s> <s sid="247"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>The corresponding C-terminal peptide (100 µl of 10 mM solution) was added and the ligation was monitored by analytical reversed phase HPLC.</text></s> <s sid="248"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>Gradient: 0–5 min, 5percent B; 5–15 min, 5 → 20percent B; 15–20 min, 20 → 50percent B; flow 1 ml min−1.</text></s> <s sid="249"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/><text>The eluted peptides were identified by coupled electrospray mass spectrometry.</text></s> <s sid="250"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs47" novelty="None" advantage="None"/><text>ESI-MS m/z: calcd. for Leu-Tyr-Lys-Ala-Gly-COSBn (25), C33H48N6O6S [M + H]: 657.3, found: 657.3; calcd. for Cys-Arg-Ala-Glu-Tyr-Ser (27), C29H46N9O11S [M + H]: 728.3, found 728.4; calcd. for Isocys-Arg-Ala-Glu-Tyr-Ser (16), C29H46N9O11S [M + H]: 728.3, found: 728.4; calcd. for Leu-Tyr-Lys-Ala-Gly-Cys-Arg-Ala-Glu-Tyr-Ser (28), C55H86N15O17S [M + H]: 1260.6, found: 1260.5; calcd.; for Leu-Tyr-Lys-Ala-Gly-Isocys-Arg-Ala-Glu-Tyr-Ser (26), C55H86N15O17S [M + H]: 1260.6, found: 1260.4.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Determination of the pH–rate profile</HEADER><P><s sid="251"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>Aliquots (50 µl) of the ligation mixture were diluted with 20percent TFA (30 µl) and analysed by RP-HPLC.</text></s> <s sid="252"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>The extinction coefficients at 280 nm of 16, 25 and 27 were equal as judged by the peak areas obtained upon HPLC-analysis of equimolar mixtures.</text></s> <s sid="253"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>The extinction coefficient of the ligation products 26 and 28 was calculated as the sum of the extinction coefficient of 16 and 25 or 25 and 27, respectively.</text></s> <s sid="254"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>These estimations were reasonable since a) extinction coefficients at 280 nm are determined by the Tyr-absorbance with one tyrosine in 16, 25, 27 and two tyrosine residues in the ligation products 26 and 28, b) hydrolysis of the benzylmercaptan thioester 25 furnished a product which showed an unchanged peak area, thereby confirming that the benzylmercaptan is a weak chromophore at 280 nm.</text></s> <s sid="255"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>The peak areas corresponding to 16, 25, 26, 27, and 28 were therefore calibrated by weighing factors of 1, 1, 0.5, 1, 0.5, respectively.</text></s> <s sid="256"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>The relative content of the ligation products was determined and plotted against the reaction time.</text></s> <s sid="257"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>The initial rates were calculated by determining the slope of the linear range of the resulting curve.</text></s> <s sid="258"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/><text>A plot of the initial rates of Cys- and Isocys-mediated ligations against the pH-value furnished the pH–rate profile depicted in Fig. 3.</text></s></P></DIV></DIV></BODY></PAPER>